Another positive step in obesity research: Julio Rosenstock, MD, is a co-author of an article now featured on The New England Journal of Medicine homepage, and in the publication’s weekend email briefing. From the article, Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity: “At week 26, the mean change from baseline in body … Read more
What do you get when you have a business economist with nursing experience? In this case, it’s one of the founding members of a clinical trials site in Berlin, Germany, which has become the latest member of Velocity’s integrated site network in Europe. Dominic Clavell, European General Manager, explained, “This is Velocity’s fourth site acquisition … Read more
Even as a teen in Egypt, Amira Nada was drawn to the idea of clinical research and how it could help people live healthier, richer lives. “When I was a young girl, I saw people around me suffering from mental and other health challenges, and I recognized they had unmet needs current treatments couldn’t alleviate,” she … Read more
Inc. magazine ranked Velocity Clinical Research 543 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. Headquartered in Durham, NC, Velocity is the world’s leading integrated site organization with 80 sites worldwide. This is Velocity’s first recognition on the list. Paul Evans, President and CEO of Velocity Clinical … Read more
More than ever, most of us have jobs that involve sitting at a desk for hours on end. The average desk worker in the U.S. is 36 years old and female. While some companies invest in workstation assessments, a lot of us are still working from home where we are less likely to have invested … Read more
Velocity is collaborating with Merck to explore a new way to engage communities about clinical research. Starting this month the Velocity team members are conducting a tour of several Southern California cities, using Merck’s iLab53, a state-of-the-art, modular 39-foot mobile research unit to reach underserved communities. At each stop, the mobile research unit will serve … Read more
At Velocity Clinical Research, we prioritize the voices of clinical trial participants, largely via the Participant Advisory Committee (PAC). Our PAC, which brings together a diverse group of past and current trial participants from across the U.S., offers a unique lens into the clinical research process. In this edition, we’ll unpack key insights gleaned from … Read more
Velocity Clinical Research, the leading integrated site organization for clinical trials, has launched a groundbreaking initiative: Councils to Accelerate Research Excellence (CARE Councils). The CARE Councils underpin Velocity’s dedication to supporting specialty research while providing comprehensive and strategically aligned solutions for Sponsors and CROs. The expert-led CARE Councils bring together seasoned physicians in their areas … Read more
Julio Rosenstock, MD, has his work spotlighted as the feature article on the New England Journal of Medicine’s homepage. Serving as the lead investigator for Novo Nordisk’s ONWARDS 1 program, Dr. Rosenstock has made remarkable strides in exploring what could be the world’s first once-weekly basal insulin. “In ONWARDS 1, insulin icodec allowed people to … Read more
For the team at Velocity Clinical Research in the United Kingdom, clinical trials are first and foremost about building relationships. “I’m really grateful to be involved in clinical trials, because it allows me to develop meaningful connections with people in a way that goes beyond the traditional and [usually] more formal doctor-patient relationship,” says Ahmed … Read more